AIM
IMCR icon

Aigen Investment Management’s Immunocore IMCR Stock Holding History

Aigen Investment Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,704
Closed -$316K – 874
2024
Q4 		$316K Sell
10,704
-5,767
-35% -$182K 0.06% 464
2024
Q3 		$513K Sell
16,471
-5,840
-26% -$212K 0.1% 318
2024
Q2 		$756K Buy
+22,311
New +$1.14M 0.15% 190
2024
Q1 		– Sell
-2,950
Closed -$202K – 842
2023
Q4 		$202K Sell
2,950
-5,119
-63% -$266K 0.04% 662
2023
Q3 		$419K Sell
8,069
-3,748
-32% -$222K 0.08% 420
2023
Q2 		$709K Buy
11,817
+6,448
+120% +$368K 0.1% 267
2023
Q1 		$265K Sell
5,369
-205
-4% -$11.5K 0.04% 454
2022
Q4 		$318K Buy
+5,574
New +$314K 0.05% 352

Other funds holding IMCR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Aigen Investment Management's IMCR Position: Q1 2025 in Review

Aigen Investment Management sold out of Immunocore (IMCR) in Q1 2025, closing a stake of 10,704 shares — an estimated $316K sold.

Aigen Investment Management first reported a position in IMCR in Q4 2022 and held it in 8 quarters. The position peaked at $756K in Q2 2024. 116 funds tracked by Wall St. Rank hold IMCR as of Q1 2025.

  • Aigen Investment Management reported no remaining Immunocore position as of Q1 2025 after selling out during the quarter.
  • Aigen Investment Management sold 10,704 Immunocore shares in Q1 2025, an estimated $316K.
  • Aigen Investment Management first reported a position in Immunocore in Q4 2022 and held it in 8 quarters.
  • Aigen Investment Management's Immunocore position peaked at $756K in Q2 2024.
  • 116 funds tracked by Wall St. Rank held Immunocore as of Q1 2025.

Based on Aigen Investment Management's 13F filing for Q1 2025, filed 12 May 2025.